Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-034422

Chief Commercial Officer sold 761 shares at $14.55 ($11,073)

From the SEC's structured data for this filing

Trades in this filing

Yarema Kristin · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-18 Sale : show line 1 in the form −761 $14.55 $11,073 91,528 D
Open-market sales · 761 sh · avg $14.55 · $11,073
Loading xslF345X03/doc4.xml…